3.14
Finanzdaten der Jupiter Neurosciences Inc-Aktie (JUNS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
29.99%
0.0242
|
0.0187 | - | - | - |
| Cost Of Revenue |
27.07%
0.00318
|
0.00436 | - | - | - |
| Gross Profit |
47.40%
0.0211
|
0.0143 | - | - | - |
|
|
39.79%
2.764
|
1.9773 | 2.8264 | 2.2971 | 2.2649 |
| Operating Income/Loss |
39.73%
-2.7429
|
-1.963 | -2.8088 | -2.2971 | -2.2649 |
| Nonoperating Income/Loss |
573.48%
0.4685
|
-0.099 | 0.2338 | 0.00902 | 0.0119 |
| Net Income/Loss |
10.30%
-2.2744
|
-2.062 | -2.575 | -2.288 | -2.253 |
| Basic Average Shares |
98.42%
0.5576
|
35.26 | - | 34.04 | 33.18 |
| Diluted Average Shares |
98.42%
0.5576
|
35.26 | - | 34.04 | 33.18 |
| Basic Earnings Per Share |
6,700%
-4.08
|
-0.06 | - | -0.07 | -0.07 |
| Diluted Earnings Per Share |
6,700%
-4.08
|
-0.06 | - | -0.07 | -0.07 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):